// App-Quantinova.ai

: Empagliflozin and Cardiorenal Outcomes in Patients with Nonproteinuric Kidney Disease in the EMPA-REG OUTCOME Trial

Researchers

Presenter

  • SILVIO E. INZUCCHI

Principal Investigators

  • BERNARD ZINMAN

  • JYOTHIS GEORGE

  • MICHAELA MATTHEUS

  • MAXIMILIAN VON EYNATTEN

  • CHRISTOPH WANNER

Medical Centers

  • N/A

Locations

  • United States

  • Canada

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

Disease

  • Chronic kidney disease

  • Type 2 diabetes mellitus

  • Renal disease

  • Albuminuria

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • BI-10773

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved